Sustainability Report 2024
V-OVS® next: A new standard for Luer Lock syringe closure systems
News
Stay up to date on what's happening at Vetter.
CDMO Insights
Sharpen your edge with our expertise.
Job Vacancies
After a complete revision of the EU GMP Annex 1, the final version was published in August 2022 and became effective just a few days ago on August 25,…
08/28/2023
Proven Process to Optimize Commercial Readiness
08/21/2023
John K. Moore, Vetter’s Director of Global Clinical Business Development, shares his biggest takeaways from the event.
06/13/2023
A successful pharmaceutical tech transfer demands adherence to detail and thorough project management. An experienced CDMO with the respective…
12/09/2022
Developing an injectable drug product with known stability limits? Learn how to weigh the pros and cons of reformulation, freezing, and…
09/06/2022
Applying a sustainable mindset can offer a competitive advantage in both the industry and the community.
05/17/2022
As 2022 takes shape, our industry finds itself at a point few of us expected: the start of a third year in this truly extraordinary era.
03/16/2022
See where you need to focus if you’re planning to launch in an autoinjector, pen, or other patient-friendly delivery device.
12/14/2021
The field of drug development can be risky and a costly investment - mistakes can mean the success or failure of a compound or even a company.
10/01/2021
How Global Trends Are Driving Patient-Centricity in Parenteral Products.
08/11/2021
Fast, safe and efficient: the new Vetter ID determination of oligonucleotides.
06/21/2021
Interview with Oskar Gold, SVP Asia Pacific and Global Emerging Markets
04/19/2021
